Related Experiment Videos

Heat shock proteins--modulators of apoptosis in tumour cells

E M Creagh1, D Sheehan, T G Cotter

  • 1Department of Biochemistry, University College Cork, Lee Maltings, Prospect Row, Ireland.

Leukemia
|July 29, 2000
PubMed

Insights

Heat shock proteins (hsps) confer resistance to apoptosis, a programmed cell death. Understanding how hsps protect cells could lead to new leukemia therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptosis is a genetically programmed process of cell death crucial for physiological regulation.
  • Heat shock proteins (hsps) are known to increase resistance to apoptosis induced by cytotoxic agents.
  • Hsp involvement in tumor resistance and carcinogenesis highlights their clinical relevance.

Purpose of the Study:

  • To review the current understanding of apoptosis.
  • To elucidate the modulatory effects of heat shock proteins (hsps) on apoptosis.
  • To discuss proposed mechanisms of hsp-mediated apoptosis protection and therapeutic implications in leukemia.

Main Methods:

  • Literature review of apoptosis mechanisms.
  • Analysis of heat shock protein (hsp) roles in cell death pathways.
  • Discussion of proposed molecular mechanisms for hsp protection.
  • Exploration of therapeutic strategies targeting hsps in leukemia.

Main Results:

  • Heat shock proteins (hsps) are implicated in resistance to apoptosis.
  • The precise mechanisms of hsp-mediated protection against apoptosis require further definition.
  • Several hypotheses propose how hsps modulate apoptotic pathways.

Conclusions:

  • Elucidating hsp-apoptosis mechanisms may reveal novel therapeutic targets for leukemia.
  • Understanding hsp function is critical for developing more effective cancer treatments.
  • Further research into hsps offers potential for overcoming chemotherapeutic resistance.

Related Concept Videos